A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study (Q57917574)
Jump to navigation
Jump to search
scientific article published on 01 November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study |
scientific article published on 01 November 2006 |
Statements
A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study (English)
E Nitta
T Sato
Y Ota
A Kamijo
K Takahashi
K Oshima
Y Kanda
S Chiba
T Motokura
1 November 2006